Multiple studies have shown that the occurrence of this polymorphism was associated with a lower risk of type 2 diabetes as well as improved insulin sensitivity in humans, suggesting that this amino acid change enhances the action of insulin [258,259]. The gene discussed is INS; the disease is type 2 diabetes mellitus.